|
animals |
25 |
|
humans |
25 |
|
sars-cov-2 |
22 |
|
mouse |
20 |
|
mice |
19 |
|
cell line |
16 |
|
covid-19 |
16 |
|
rat |
15 |
|
omicron |
14 |
|
base sequence |
13 |
|
kinetics |
13 |
|
sars-cov-2 variants |
13 |
|
covid-19 vaccines |
12 |
|
innate immunity |
12 |
|
molecular sequence data |
12 |
|
tuberculosis |
12 |
|
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
|
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
|
murine |
11 |
|
n501y |
11 |
|
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
|
severe acute respiratory syndrome - drug therapy |
11 |
|
spike protein |
11 |
|
susceptibility |
11 |
|
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
|
fluorescent antibody technique, indirect |
10 |
|
kif5b |
10 |
|
linker-immunodominant site |
10 |
|
transfection |
10 |
|
vaccine |
10 |
|
adenosine synthase a |
9 |
|
aged mice |
9 |
|
chromosome aberrations |
9 |
|
dna damage - genetics |
9 |
|
dna repair - physiology |
9 |
|
enzyme-linked immunosorbent assay |
9 |
|
genome mutation |
9 |
|
human primary nasal epithelial cells |
9 |
|
human respiratory syncytial virus |
9 |
|
lethal mouse model |
9 |
|
lung pathology |
9 |
|
male |
9 |
|
post-ba.2/5 subvariants |
9 |
|
weanling mice |
9 |
|
aging, premature - genetics |
8 |
|
alleles |
8 |
|
antiviral agents - chemical synthesis - pharmacology |
8 |
|
biology |
8 |
|
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
|
bone marrow cells - physiology - radiation effects |
8 |
|
cell aging - genetics |
8 |
|
cercopithecus aethiops |
8 |
|
chromosomal proteins, non-histone |
8 |
|
coronavirus |
8 |
|
dna - genetics |
8 |
|
dna-binding proteins - genetics - metabolism |
8 |
|
female |
8 |
|
fibroblasts - pathology - radiation effects |
8 |
|
gamma rays |
8 |
|
genomic instability |
8 |
|
histones - genetics - metabolism - radiation effects |
8 |
|
immunotherapy |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
lamin type a - genetics - metabolism |
8 |
|
membrane proteins - genetics - metabolism |
8 |
|
metalloendopeptidases - genetics - metabolism |
8 |
|
mice, mutant strains |
8 |
|
neuroscience |
8 |
|
nuclear proteins - genetics - metabolism |
8 |
|
phosphoproteins - genetics - metabolism |
8 |
|
protein precursors - genetics - metabolism |
8 |
|
rad51 recombinase |
8 |
|
sars coronavirus |
8 |
|
seroepidemiology |
8 |
|
spike |
8 |
|
adaptation, physiological - genetics |
7 |
|
antibodies, viral - blood |
7 |
|
antibodies, viral - genetics - immunology - metabolism |
7 |
|
cells, cultured |
7 |
|
coronavirus - classification - genetics - immunology - metabolism |
7 |
|
coronavirus - immunology |
7 |
|
coronavirus hku1 |
7 |
|
coronavirus infections - epidemiology - immunology |
7 |
|
cricetinae |
7 |
|
dna primers |
7 |
|
enzyme inhibitors - chemical synthesis - pharmacology |
7 |
|
fluorescein-5-isothiocyanate - metabolism |
7 |
|
fluorescent dyes - metabolism |
7 |
|
furin inhibitor |
7 |
|
gene expression regulation, bacterial |
7 |
|
genome, bacterial |
7 |
|
genotype |
7 |
|
glycoprotein |
7 |
|
glycosylation |
7 |
|
hbv infection |
7 |
|
hela cells |
7 |
|
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
|
human coronavirus hku1 |
7 |
|
ifnar1 |
7 |
|
immunization |
7 |
|
kidney - cytology |
7 |
|
kinesin-1 |
7 |
|
life cycle |
7 |
|
maturation |
7 |
|
membrane glycoproteins - genetics - immunology - metabolism |
7 |
|
membrane glycoproteins - immunology |
7 |
|
mice, inbred balb c |
7 |
|
native conformation |
7 |
|
neisseriaceae - genetics |
7 |
|
neutralization antibody |
7 |
|
nglycosylation |
7 |
|
nlrp3 inflammasome |
7 |
|
physiological processes - genetics |
7 |
|
polymorphism, single nucleotide |
7 |
|
promoter regions, genetic |
7 |
|
proteome |
7 |
|
receptor, interferon alpha-beta - genetics |
7 |
|
recombinant proteins - immunology - metabolism |
7 |
|
recombination, genetic |
7 |
|
snp |
7 |
|
staphylococcus aureus |
7 |
|
surface expression |
7 |
|
t cell responses |
7 |
|
temperature |
7 |
|
transcription regulation |
7 |
|
viral envelope proteins - genetics - immunology - metabolism |
7 |
|
virus maturation |
7 |
|
virus replication - drug effects |
7 |
|
adenosine triphosphatases - metabolism |
6 |
|
antigenic cartography |
6 |
|
antigenic distance |
6 |
|
antigenic field |
6 |
|
antiviral agents |
6 |
|
apoptosis |
6 |
|
binding sites |
6 |
|
bismuth |
6 |
|
bismuth - chemistry - pharmacology |
6 |
|
booster vaccine |
6 |
|
cell line, tumor |
6 |
|
cellular neuroscience |
6 |
|
coronavirus - physiology |
6 |
|
cysteine - chemistry |
6 |
|
dna helicases - antagonists & inhibitors |
6 |
|
dna helicases - classification - genetics - metabolism |
6 |
|
dna, viral - genetics - metabolism |
6 |
|
enzymes |
6 |
|
epithelial cells - virology |
6 |
|
flow cytometry |
6 |
|
gene silencing |
6 |
|
helical structures |
6 |
|
hepatitis b virus |
6 |
|
hla-c antigens - genetics - metabolism |
6 |
|
immune imprinting |
6 |
|
macaca mulatta |
6 |
|
membrane glycoproteins - metabolism |
6 |
|
molecular neuroscience |
6 |
|
mrsa |
6 |
|
mutation |
6 |
|
mutation - genetics |
6 |
|
nucleic acid conformation - drug effects |
6 |
|
nucleoside-triphosphatase - classification - genetics - metabolism |
6 |
|
organometallic compounds - chemistry - pharmacology |
6 |
|
protein binding |
6 |
|
protein structure, tertiary |
6 |
|
proteomics - methods |
6 |
|
receptors, virus - genetics - metabolism |
6 |
|
rna helicases - classification - genetics - metabolism |
6 |
|
salmonella typhimurium |
6 |
|
sars virus |
6 |
|
sars virus - drug effects |
6 |
|
sars virus - enzymology - genetics |
6 |
|
sars-cov-1 |
6 |
|
severe acute respiratory syndrome |
6 |
|
substrate specificity |
6 |
|
transgenic mouse |
6 |
|
vaccine seed strain selection |
6 |
|
vero cells |
6 |
|
viral envelope proteins - metabolism |
6 |
|
virus attachment |
6 |
|
aging |
5 |
|
amino acid sequence |
5 |
|
amino acid substitution - genetics |
5 |
|
axonal injury |
5 |
|
axonal regeneration |
5 |
|
bacterial proteins - drug effects - genetics - metabolism |
5 |
|
bismuth - chemistry |
5 |
|
blotting, western |
5 |
|
chi-square distribution |
5 |
|
chromosomes, artificial, bacterial |
5 |
|
colloidal bismuth subcitrate |
5 |
|
construction strategies |
5 |
|
desmin |
5 |
|
disease susceptibility |
5 |
|
dna helicases - antagonists and inhibitors |
5 |
|
dna-binding proteins - metabolism |
5 |
|
esophageal cancer |
5 |
|
exostoses, multiple hereditary - genetics |
5 |
|
exostosis |
5 |
|
ext2 |
5 |
|
gene expression profiling |
5 |
|
gene expression profiling - methods |
5 |
|
gene expression regulation, bacterial - drug effects |
5 |
|
gene frequency |
5 |
|
gene therapy |
5 |
|
genetic engineering - methods |
5 |
|
genetic predisposition to disease |
5 |
|
glucuronidase - genetics |
5 |
|
glycosyltransferases |
5 |
|
helicobacter pylori |
5 |
|
helicobacter pylori - chemistry - drug effects - genetics |
5 |
|
hepatitis b, chronic - genetics |
5 |
|
hepatitis b, chronic - genetics - virology |
5 |
|
ifngr1 |
5 |
|
immobilized-metal affinity chromatography |
5 |
|
immunological comparison |
5 |
|
live oral vaccine |
5 |
|
logistic models |
5 |
|
luciferases - genetics - metabolism |
5 |
|
luminescent measurements |
5 |
|
lymph node metastasis |
5 |
|
metabolic reprogramming |
5 |
|
metalloproteins - analysis - genetics |
5 |
|
metastasis |
5 |
|
mice, transgenic |
5 |
|
microbial sensitivity tests |
5 |
|
motoneuron |
5 |
|
multiple osteochondromas |
5 |
|
mutation, missense |
5 |
|
myofibrils |
5 |
|
myotendinous junctions |
5 |
|
n-acetylglucosaminyltransferases - genetics |
5 |
|
nestin |
5 |
|
neuroblastoma |
5 |
|
nickel - metabolism |
5 |
|
nrf2 |
5 |
|
odds ratio |
5 |
|
organometallic compounds - chemical synthesis - pharmacology |
5 |
|
organometallic compounds - pharmacology |
5 |
|
oxidative phosphorylation |
5 |
|
point mutation |
5 |
|
polymorphism, restriction fragment length |
5 |
|
promoter activity |
5 |
|
promoter regions, genetic - genetics |
5 |
|
protease inhibitors |
5 |
|
protein stability |
5 |
|
proteomics |
5 |
|
purkinje cells - enzymology |
5 |
|
reactive oxygen species |
5 |
|
receptor, interferon alpha-beta - biosynthesis - genetics |
5 |
|
receptors, interferon - genetics |
5 |
|
rna, messenger - metabolism |
5 |
|
rna, small interfering |
5 |
|
s. aureus |
5 |
|
sequence analysis, dna |
5 |
|
soluble and insoluble antigens |
5 |
|
synthetic biology |
5 |
|
transcription factor |
5 |
|
acyl-butyrolactones - metabolism |
4 |
|
adamantane - analogs & derivatives - chemistry - pharmacology |
4 |
|
adeno-associated virus |
4 |
|
adsa |
4 |
|
adult |
4 |
|
antigens - genetics - metabolism |
4 |
|
antiviral agents - chemistry - pharmacology |
4 |
|
antiviral agents - pharmacology |
4 |
|
asian continental ancestry group |
4 |
|
axonal transport |
4 |
|
bacterial load |
4 |
|
bacterial proteins - metabolism |
4 |
|
beta-galactosidase - metabolism |
4 |
|
bipolar cells |
4 |
|
carcinoma, hepatocellular - metabolism |
4 |
|
cdc2 protein kinase - metabolism |
4 |
|
cdc25 phosphatases - metabolism |
4 |
|
cell biology |
4 |
|
cell division |
4 |
|
cell proliferation |
4 |
|
cell transformation, neoplastic |
4 |
|
cerebellum |
4 |
|
chromosome instability |
4 |
|
chromosome segregation |
4 |
|
cloning, molecular |
4 |
|
cloning, molecular - methods |
4 |
|
clostridium difficile |
4 |
|
cp: neuroscience |
4 |
|
cross protection |
4 |
|
culture media |
4 |
|
cytopathogenic effect, viral |
4 |
|
dendritic spine |
4 |
|
dependovirus |
4 |
|
diffusion |
4 |
|
disease prevalence |
4 |
|
disease progression |
4 |
|
dna helicases - antagonists & inhibitors - metabolism |
4 |
|
dna helicases - antagonists and inhibitors - chemistry - physiology |
4 |
|
dna helicases - metabolism |
4 |
|
dna vaccine |
4 |
|
dogs |
4 |
|
dose-response relationship, drug |
4 |
|
eif-5a2 aging |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
enzyme inhibitors - chemistry - pharmacology |
4 |
|
escherichia coli |
4 |
|
escherichia coli - genetics |
4 |
|
escherichia coli k12 - cytology - genetics - growth & development - physiology |
4 |
|
european continental ancestry group |
4 |
|
fear learning |
4 |
|
fmrp |
4 |
|
frontal association cortex |
4 |
|
g2 phase |
4 |
|
galactosides - metabolism |
4 |
|
gene expression |
4 |
|
gene expression regulation, viral |
4 |
|
gene expression regulation, viral - immunology |
4 |
|
gene regulatory networks |
4 |
|
gene transfer/gene therapy |
4 |
|
genetic susceptibility |
4 |
|
genetic vectors - genetics |
4 |
|
gephyrin |
4 |
|
green fluorescent proteins - genetics - metabolism |
4 |
|
guanine nucleotide exchange factors |
4 |
|
h7n9 |
4 |
|
helicobacter pylori - metabolism |
4 |
|
hep g2 cells |
4 |
|
hepatitis b - therapy |
4 |
|
hepatitis b antigens - metabolism |
4 |
|
hepatitis b virus - immunology - metabolism |
4 |
|
histidine-rich protein |
4 |
|
hpn |
4 |
|
hydrodynamic transfection |
4 |
|
immunotherapy - methods |
4 |
|
in vivo two-photon imaging |
4 |
|
indoles - metabolism |
4 |
|
influenza a virus |
4 |
|
influenza a virus, h1n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
|
inhibition of scov reproduction |
4 |
|
integrases - genetics - metabolism |
4 |
|
interferon-alpha - metabolism |
4 |
|
interferon-α1 |
4 |
|
interneurons - enzymology |
4 |
|
liver neoplasms - metabolism |
4 |
|
m2e |
4 |
|
mice, inbred c3h |
4 |
|
mice, inbred c57bl |
4 |
|
mice, knockout |
4 |
|
middle aged |
4 |
|
models, biological |
4 |
|
models, molecular |
4 |
|
movement |
4 |
|
multifactor dimensionality reduction |
4 |
|
multivalent vaccine |
4 |
|
neuropeptides - genetics |
4 |
|
nickel |
4 |
|
nucleocapsid proteins - genetics - metabolism |
4 |
|
oncogene |
4 |
|
orthomyxoviridae infections - virology |
4 |
|
pcr-rflp |
4 |
|
peptide vaccine |
4 |
|
polymorphism, genetic |
4 |
|
pregnancy |
4 |
|
proteins - metabolism |
4 |
|
psd95 |
4 |
|
pyridines - chemistry - pharmacology |
4 |
|
quorum sensing |
4 |
|
recombineering salmonella vaccine |
4 |
|
retinal development |
4 |
|
retinal rod photoreceptor cells - cytology - embryology |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
rna interference |
4 |
|
rna, messenger - genetics - metabolism |
4 |
|
rna, small interfering - genetics |
4 |
|
salmonella typhi - genetics - metabolism |
4 |
|
sars virus - drug effects - enzymology |
4 |
|
sars virus - drug effects - enzymology - physiology |
4 |
|
sars virus - enzymology - genetics - pathogenicity - physiology |
4 |
|
sars-associated coronavirus |
4 |
|
serial passage |
4 |
|
sirna |
4 |
|
storage |
4 |
|
synaptic protein translocation |
4 |
|
time factors |
4 |
|
toxin a (tcda) |
4 |
|
toxin b (tcdb) |
4 |
|
tumor markers, biological - metabolism |
4 |
|
up-regulation |
4 |
|
vaccines |
4 |
|
viral kinetics |
4 |
|
viral matrix proteins - genetics |
4 |
|
viral proteins - genetics |
4 |
|
virus assembly |
4 |
|
virus replication |
4 |
|
virus replication - drug effects - physiology |
4 |
|
virus replication - immunology |
4 |
|
virus replication - physiology |
4 |
|
yb1 |
4 |
|
zinc - metabolism |
4 |
|
γδ t cell |
4 |
|
adaptor proteins, signal transducing - drug effects - genetics - metabolism |
3 |
|
adenoviridae - genetics |
3 |
|
alzheimer's disease |
3 |
|
amyloid-β formation |
3 |
|
anaerobic salmonella |
3 |
|
anti-pd therapy |
3 |
|
antibodies, viral - biosynthesis |
3 |
|
antibody |
3 |
|
antiviral drugs |
3 |
|
antivirals |
3 |
|
apoptosis - genetics - physiology |
3 |
|
ataxia |
3 |
|
bac |
3 |
|
bacterial proteins - chemistry - genetics |
3 |
|
bacterial therapy |
3 |
|
bananin |
3 |
|
binding, competitive |
3 |
|
cancer treatment |
3 |
|
cell adhesion molecules - genetics - metabolism |
3 |
|
cell cycle - physiology |
3 |
|
cell lineage - genetics |
3 |
|
cell migration |
3 |
|
cell movement |
3 |
|
cell movement - genetics |
3 |
|
central spindle |
3 |
|
cerebellum - enzymology |
3 |
|
cerebellum development |
3 |
|
chondrocytes |
3 |
|
chromosome mapping |
3 |
|
chromosomes, bacterial - chemistry |
3 |
|
cold tumor |
3 |
|
cold-inducible rna binding protein |
3 |
|
collagenase mice model |
3 |
|
computer simulation |
3 |
|
copper sulfate - chemistry - pharmacology |
3 |
|
corticospinal tract integrity |
3 |
|
cre recombinase |
3 |
|
cytokinesis |
3 |
|
dependovirus - genetics - metabolism |
3 |
|
dna helicases - genetics - pharmacology |
3 |
|
dna helicases - genetics - physiology |
3 |
|
dna mismatch repair - genetics - physiology |
3 |
|
dna repair enzymes |
3 |
|
dna, bacterial - chemistry |
3 |
|
dna, complementary - genetics |
3 |
|
dna, recombinant - genetics |
3 |
|
dna, single-stranded - genetics |
3 |
|
dna, single-stranded - genetics - metabolism |
3 |
|
dna-binding proteins - genetics - physiology |
3 |
|
drug delivery systems |
3 |
|
drug evaluation, preclinical |
3 |
|
edetic acid - chemistry |
3 |
|
electroporation |
3 |
|
embryo, nonmammalian - cytology |
3 |
|
escherichia coli - chemistry - genetics |
3 |
|
escherichia coli - drug effects - genetics - growth & development |
3 |
|
escherichia coli - enzymology - genetics - growth & development |
3 |
|
escherichia coli proteins - analysis - genetics |
3 |
|
escherichia coli proteins - metabolism |
3 |
|
eukaryota |
3 |
|
fluorescent dyes - analysis |
3 |
|
gene expression regulation, developmental |
3 |
|
gene expression regulation, enzymologic |
3 |
|
gene targeting |
3 |
|
genes, reporter |
3 |
|
genes, suppressor |
3 |
|
genetic markers |
3 |
|
genetic vectors |
3 |
|
hemorrhagic stroke |
3 |
|
hepatocellular carcinoma |
3 |
|
high-dose radiation |
3 |
|
hydrogen-ion concentration |
3 |
|
immune response |
3 |
|
immune-compromised host |
3 |
|
immunodominant site |
3 |
|
integrases - genetics |
3 |
|
inter-kingdom delivery and dual expression (ikde) |
3 |
|
intracerebral hemorrhage |
3 |
|
intrinsic apoptosis |
3 |
|
l7 |
3 |
|
laser-enhanced immunotherapy |
3 |
|
lethal rsv strain |
3 |
|
linear epitopes |
3 |
|
live attenuated s. typhimurium vaccine |
3 |
|
liver neoplasms, experimental - chemically induced - genetics - pathology |
3 |
|
low-dose radiation |
3 |
|
luminescent proteins - analysis - genetics |
3 |
|
macrophage |
3 |
|
mammalia |
3 |
|
metals - chemistry - pharmacology |
3 |
|
methionine adenosyltransferase - analysis - genetics |
3 |
|
microscopy, fluorescence |
3 |
|
morphogenetic lineage migration |
3 |
|
motor activity |
3 |
|
muts dna mismatch-binding protein - metabolism |
3 |
|
neoantigen vaccine |
3 |
|
nerve tissue proteins - antagonists & inhibitors - genetics - physiology |
3 |
|
neural development |
3 |
|
neutralization |
3 |
|
neutralization tests |
3 |
|
neutralizing antibodies |
3 |
|
nickel - chemistry - pharmacology |
3 |
|
oligonucleotides - genetics |
3 |
|
oligonucleotides - genetics - metabolism |
3 |
|
orthotopic mouse model |
3 |
|
pcp2 |
3 |
|
pdss2 |
3 |
|
plasmids - genetics |
3 |
|
positive-feedback loop |
3 |
|
prokaryota |
3 |
|
proteins - chemistry - genetics |
3 |
|
proteome - analysis - genetics |
3 |
|
purkinje cell |
3 |
|
purkinje cells |
3 |
|
radiotherapy |
3 |
|
ranitidine - analogs & derivatives - chemistry - pharmacology |
3 |
|
receptor-binding domain |
3 |
|
receptors, virus - metabolism |
3 |
|
recombinant fusion proteins - analysis |
3 |
|
recombinant proteins - metabolism |
3 |
|
respiratory syncytial virus |
3 |
|
responsive drug release |
3 |
|
rna - biosynthesis - genetics |
3 |
|
rna, antisense - genetics - pharmacology |
3 |
|
rna, small interfering - biosynthesis - genetics - pharmacology |
3 |
|
rna-binding proteins - antagonists & inhibitors - genetics - physiology |
3 |
|
rotenone |
3 |
|
saesxa |
3 |
|
saesxb |
3 |
|
salvianolic acid b |
3 |
|
sars virus - drug effects - genetics |
3 |
|
sars virus - drug effects - genetics - physiology |
3 |
|
sars virus - immunology |
3 |
|
sars-cov |
3 |
|
sensitivity and specificity |
3 |
|
sequence deletion |
3 |
|
severe acute respiratory syndrome - drug therapy - genetics - virology |
3 |
|
signal transduction - genetics |
3 |
|
single-stranded oligonucleotide |
3 |
|
species index: bacteria (microorganisms) |
3 |
|
spinal cord |
3 |
|
spinal cord changes |
3 |
|
strand bias |
3 |
|
systemic tumor immune environment (stie) |
3 |
|
t cell response |
3 |
|
t3ss |
3 |
|
targeted gene repair |
3 |
|
tgcrnd8 mice |
3 |
|
thermodynamics |
3 |
|
thymidine |
3 |
|
thymidylate synthase - genetics |
3 |
|
transferases - analysis - genetics |
3 |
|
tumor growth |
3 |
|
tumor immune microenvironment (time) |
3 |
|
tumor metastasis |
3 |
|
tumor-targeting salmonella |
3 |
|
ubiquinone deficiency |
3 |
|
variants |
3 |
|
vero cells - cytology - drug effects |
3 |
|
viral helicase |
3 |
|
viral vaccines - immunology |
3 |
|
virus replication - drug effects - genetics |
3 |
|
xenopus |
3 |
|
xenopus laevis - embryology - genetics - metabolism |
3 |
|
xenopus proteins - antagonists & inhibitors - genetics - physiology |
3 |
|
zinc sulfate - chemistry - pharmacology |
3 |
|
adam10 |
2 |
|
adaptation, physiological |
2 |
|
agar plates |
2 |
|
alzheimer disease - blood - complications - pathology - psychology |
2 |
|
alzheimer’s disease |
2 |
|
amino acid substitution |
2 |
|
amyloid beta-peptides - antagonists & inhibitors - biosynthesis - toxicity |
2 |
|
amyloid-β |
2 |
|
antioxidants - pharmacology |
2 |
|
aromatic trace amines |
2 |
|
aβ aggregating elisa |
2 |
|
bacterial proteins - genetics - metabolism |
2 |
|
bacterial systems |
2 |
|
behavior, animal |
2 |
|
benzofurans - pharmacology |
2 |
|
brain - metabolism - pathology |
2 |
|
cancer |
2 |
|
carrier proteins - genetics - metabolism |
2 |
|
cell aggregation - drug effects |
2 |
|
cell cycle proteins - metabolism |
2 |
|
cell density |
2 |
|
cell-free |
2 |
|
chimeraplasty |
2 |
|
chinese medicine |
2 |
|
circular dichroism |
2 |
|
circular dichroism spectroscopy |
2 |
|
colonic secretion |
2 |
|
cryptotanshinone |
2 |
|
cytotoxicity |
2 |
|
data interpretation, statistical |
2 |
|
differentiating myoblasts |
2 |
|
dna breaks, single-stranded |
2 |
|
dna damage |
2 |
|
dna helicases - chemistry |
2 |
|
dna repair |
2 |
|
dna repair - genetics |
2 |
|
dna, bacterial - genetics |
2 |
|
dna, single-stranded - metabolism |
2 |
|
double-stranded break |
2 |
|
drug design |
2 |
|
dynein |
2 |
|
egfp reporter system |
2 |
|
electron microscopy |
2 |
|
engineered salmonella |
2 |
|
escherichia coli - genetics - metabolism |
2 |
|
escherichia coli proteins - genetics - metabolism |
2 |
|
front profile |
2 |
|
gastrointestinal motility |
2 |
|
gene knockout techniques |
2 |
|
gene repair |
2 |
|
gene targeting - methods |
2 |
|
gene therapy - methods |
2 |
|
gene transfer techniques |
2 |
|
green fluorescent proteins - genetics |
2 |
|
gut microbiota |
2 |
|
helicase structure |
2 |
|
homologous recombination repair |
2 |
|
hypoxia |
2 |
|
insulin - deficiency - secretion |
2 |
|
insulin-secreting cells - drug effects - physiology |
2 |
|
irritable bowel syndrome |
2 |
|
kidney - physiology |
2 |
|
kinesin |
2 |
|
kinesin - antagonists and inhibitors - chemistry - deficiency - drug effects - genetics |
2 |
|
kinesin i |
2 |
|
lipoproteins - genetics - metabolism |
2 |
|
membrane glycoproteins - analysis - chemistry |
2 |
|
microfibrils - drug effects - ultrastructure |
2 |
|
microscopy, electron |
2 |
|
models, chemical |
2 |
|
molecular modeling |
2 |
|
mrna vaccine |
2 |
|
mutant enhanced green fluorescence protein gene (megfp) |
2 |
|
myotubes |
2 |
|
oligonucleotide |
2 |
|
oligonucleotides - administration & dosage - genetics |
2 |
|
oligonucleotides - metabolism |
2 |
|
phenethylamine |
2 |
|
pkc |
2 |
|
plaque, amyloid - blood - complications - pathology |
2 |
|
point mutation - genetics |
2 |
|
polymorphism, single nucleotide - genetics |
2 |
|
prevent transmission |
2 |
|
protein conformation |
2 |
|
protein structure |
2 |
|
protein structure, quaternary |
2 |
|
protein-serine-threonine kinases - metabolism |
2 |
|
quaternary structure prediction |
2 |
|
recombination |
2 |
|
recombination, genetic - genetics |
2 |
|
recombination, genetic - physiology |
2 |
|
rna, untranslated - genetics - metabolism |
2 |
|
rna-binding proteins - genetics - metabolism |
2 |
|
rna/dna oligonucleotide |
2 |
|
salmonella |
2 |
|
sars virus - enzymology |
2 |
|
sequence analysis, protein |
2 |
|
sequence analysis, protein - methods |
2 |
|
serotonin |
2 |
|
sigma factor - genetics - metabolism |
2 |
|
spike glycoprotein |
2 |
|
stress, psychological - blood - complications - pathology |
2 |
|
structure prediction |
2 |
|
structure-activity relationship |
2 |
|
superneut mask |
2 |
|
syrian hamster model |
2 |
|
target-killing |
2 |
|
targeted gene correction |
2 |
|
targeted gene repair - methods |
2 |
|
tetrazolium salts |
2 |
|
thiazoles - pharmacology |
2 |
|
thioflavine t |
2 |
|
trace amine-associated receptor 1 |
2 |
|
transcriptional activation - genetics |
2 |
|
transfection - methods |
2 |
|
tryptamine |
2 |
|
tumor suppressor proteins - metabolism |
2 |
|
viral envelope proteins - analysis - chemistry |
2 |
|
viral proteins - chemistry |
2 |
|
xenograft |
2 |
|
β-amyloid fibrils |
2 |
|
λ-red |
2 |
|
(drosophila) |
1 |
|
3t3-l1 cell |
1 |
|
acetyl-coa |
1 |
|
actins - genetics - physiology |
1 |
|
adhesion molecules |
1 |
|
adipocyte |
1 |
|
adipogenesis and lipolysis |
1 |
|
adipokine |
1 |
|
adiponectin secretion |
1 |
|
alpha-synuclein |
1 |
|
alpha-synuclein - antagonists & inhibitors - chemistry |
1 |
|
alternative splicing |
1 |
|
alzheheimer’s disease |
1 |
|
alzheimer disease - drug therapy |
1 |
|
amyloid - biosynthesis |
1 |
|
amyloid beta-peptides |
1 |
|
angiotensin-converting enzyme 2 |
1 |
|
animal cell |
1 |
|
animal experiment |
1 |
|
animal model |
1 |
|
animal tissue |
1 |
|
anti-angiogenesis |
1 |
|
anti-inflammatory agents - pharmacology |
1 |
|
anti-virus |
1 |
|
antigen degradation assay |
1 |
|
antigen expression |
1 |
|
antiviral |
1 |
|
apoptosis - drug effects |
1 |
|
automation |
1 |
|
aβ generation |
1 |
|
bace-1 |
1 |
|
bacterial cancer therapy |
1 |
|
baicalein |
1 |
|
benzofurans |
1 |
|
bezafibrate |
1 |
|
bicoid |
1 |
|
binding threshold |
1 |
|
biofoundry |
1 |
|
biological orthogonal chemistry |
1 |
|
biological transport |
1 |
|
biological transport - physiology |
1 |
|
biomaterials |
1 |
|
blastoderm |
1 |
|
blood coagulation |
1 |
|
blood platelets |
1 |
|
brain - cytology - metabolism |
1 |
|
brain - metabolism |
1 |
|
breast cancer |
1 |
|
breast neoplasms - metabolism - pathology - secretion |
1 |
|
ca2+ |
1 |
|
cancer immunotherapy |
1 |
|
cationic liposomal delivery |
1 |
|
ccl18 |
1 |
|
cell adhesion - drug effects |
1 |
|
cell cycle |
1 |
|
cell differentiation - genetics |
1 |
|
cell polarity |
1 |
|
cell survival - drug effects |
1 |
|
chemical profiles |
1 |
|
chemical proteomics |
1 |
|
cholinesterase inhibitors - therapeutic use |
1 |
|
chromosome deletion |
1 |
|
chromosome mapping - methods |
1 |
|
chronic lung diseases |
1 |
|
clinical trial |
1 |
|
cloud lab |
1 |
|
colon - metabolism - ultrastructure |
1 |
|
colorectal cancer |
1 |
|
combined therapy |
1 |
|
consensus sequence |
1 |
|
core/shell nanoparticles |
1 |
|
corepressor |
1 |
|
covid‐19 |
1 |
|
crystallography, x-ray |
1 |
|
cytology and histology |
1 |
|
decapentaplegic |
1 |
|
delivery systems |
1 |
|
deoxyribonuclease i |
1 |
|
dihydrolipoamide dehydrogenase |
1 |
|
disease models, animal |
1 |
|
dna |
1 |
|
dna - analysis |
1 |
|
dna assembly |
1 |
|
dna mutational analysis |
1 |
|
dna mutational analysis - methods |
1 |
|
dna transposable elements |
1 |
|
dna, complementary |
1 |
|
dna-binding protein |
1 |
|
dna-binding proteins - genetics |
1 |
|
dna-directed dna polymerase - metabolism |
1 |
|
docking |
1 |
|
dorsal |
1 |
|
dorsal morphogen |
1 |
|
dorsal-ventral pattern formation |
1 |
|
dorsal/ventral pattern formation |
1 |
|
drosophila - embryology - genetics |
1 |
|
drosophila - genetics |
1 |
|
drosophila embryogenesis |
1 |
|
drosophila melanogaster - embryology - genetics |
1 |
|
drosophila proteins |
1 |
|
drug therapy, combination |
1 |
|
drugs, chinese herbal - chemistry - pharmacology |
1 |
|
e-selectin - biosynthesis |
1 |
|
egta |
1 |
|
electrolyte-gated field-effect transistors |
1 |
|
elf- 1 |
1 |
|
embryo, nonmammalian - physiology |
1 |
|
embryogenesis |
1 |
|
embryonic and fetal development |
1 |
|
embryonic induction |
1 |
|
embryonic induction - physiology |
1 |
|
embryonic stem cell |
1 |
|
embryonic stem cells |
1 |
|
endothelium, vascular - cytology - drug effects - enzymology |
1 |
|
endothelium, vascular - drug effects - metabolism |
1 |
|
enhancer elements, genetic |
1 |
|
enhancer elements, genetic - genetics |
1 |
|
enterocytes - metabolism - ultrastructure |
1 |
|
enterovirus 71 |
1 |
|
epithelial-mesenchymal transtion |
1 |
|
epithelial‑mesenchymal transition |
1 |
|
epitopes |
1 |
|
epstein-barr virus |
1 |
|
erp57 |
1 |
|
exons |
1 |
|
exons - genetics |
1 |
|
exosomes - metabolism - secretion |
1 |
|
expression |
1 |
|
extracellular vesicles |
1 |
|
fatty acid |
1 |
|
ferroptosis |
1 |
|
flavanones - chemistry - pharmacology |
1 |
|
flexible antigen display |
1 |
|
flexible biosensors |
1 |
|
fluorescent antibody technique |
1 |
|
ft-icr/ms |
1 |
|
fungal proteins - genetics |
1 |
|
gaga |
1 |
|
gal4-uas |
1 |
|
galactose |
1 |
|
gastroenteritis |
1 |
|
gene circuit |
1 |
|
gene dosage |
1 |
|
gene expression regulation |
1 |
|
genes, insect |
1 |
|
genes, recessive |
1 |
|
genetic circuits |
1 |
|
genetic materials |
1 |
|
genomic imprinting |
1 |
|
glioma |
1 |
|
glycine cleavage system h protein |
1 |
|
gpx4 |
1 |
|
grainyhead |
1 |
|
green fluorescent protein |
1 |
|
green fluorescent proteins |
1 |
|
gtp-binding protein beta subunits |
1 |
|
gut microflora |
1 |
|
hair color - genetics |
1 |
|
hemostasis |
1 |
|
herbal medicine |
1 |
|
high throughput |
1 |
|
high-throughput sequencing |
1 |
|
homeodomain proteins |
1 |
|
homeodomain proteins - metabolism |
1 |
|
human umbilical vein endothelial cells |
1 |
|
humanized mouse model |
1 |
|
hybrid nanoparticle |
1 |
|
hydrogen peroxide - pharmacology |
1 |
|
il15 |
1 |
|
immune responses |
1 |
|
immunogene therapy |
1 |
|
immunology |
1 |
|
inflammatory bowel disease |
1 |
|
insect hormones - genetics |
1 |
|
insect hormones - physiology |
1 |
|
intercellular adhesion molecule-1 - biosynthesis |
1 |
|
intermediate filament proteins - biosynthesis - genetics |
1 |
|
intermediate filament proteins - chemistry - genetics |
1 |
|
intermediate filament proteins - genetics - physiology |
1 |
|
intradermal delivery |
1 |
|
intravenous administration |
1 |
|
introns |
1 |
|
ivt mrna |
1 |
|
iκbα |
1 |
|
kif5b knockdown mice |
1 |
|
kinesin - genetics - physiology |
1 |
|
kinesins |
1 |
|
laci |
1 |
|
lacp |
1 |
|
laminar shear stress |
1 |
|
light-inducible |
1 |
|
liver metastasis |
1 |
|
liver target |
1 |
|
living functional materials |
1 |
|
lnps |
1 |
|
luminescent proteins - metabolism |
1 |
|
lung cancer |
1 |
|
lung microbiome |
1 |
|
lung–brain axis |
1 |
|
macrophages - drug effects - metabolism - secretion |
1 |
|
mads domain proteins - genetics - metabolism |
1 |
|
mass spectrometry |
1 |
|
mathematical modeling |
1 |
|
mdck cell |
1 |
|
mdck细胞 |
1 |
|
melanocytes - cytology - metabolism |
1 |
|
melanosome |
1 |
|
melanosome transfer |
1 |
|
metabolomics |
1 |
|
metal oxides |
1 |
|
mhc-peptide binding |
1 |
|
mice - genetics |
1 |
|
mice, inbred strains |
1 |
|
microneedle |
1 |
|
micrornas - genetics - metabolism - secretion |
1 |
|
microtubule |
1 |
|
microtubules - physiology |
1 |
|
microvilli - metabolism - ultrastructure |
1 |
|
molecular biology |
1 |
|
molecular motor proteins - genetics - metabolism |
1 |
|
molecular motor proteins - physiology |
1 |
|
molecular motors |
1 |
|
molecular structure |
1 |
|
monomeric gtp-binding proteins - genetics |
1 |
|
morphogen gradient |
1 |
|
morphogenesis |
1 |
|
morphogenesis - genetics |
1 |
|
motif sampling |
1 |
|
motor protein |
1 |
|
mrna therapy |
1 |
|
mt: regular issue |
1 |
|
multi-input |
1 |
|
multi-targeting vaccine |
1 |
|
multiple sclerosis |
1 |
|
mutagenesis |
1 |
|
mutagenesis, insertional |
1 |
|
myosin |
1 |
|
myosin 5a |
1 |
|
myosin heavy chains |
1 |
|
myosin heavy chains - deficiency - genetics - metabolism |
1 |
|
myosin heavy chains - genetics - metabolism |
1 |
|
myosin type i |
1 |
|
myosin type v |
1 |
|
myosin type v - genetics - metabolism |
1 |
|
myosin-va |
1 |
|
myosins - genetics |
1 |
|
naive cd4+ t cells |
1 |
|
nanocomplexes |
1 |
|
nasopharyngeal carcinoma |
1 |
|
natural killer cells |
1 |
|
neurological agents |
1 |
|
new life forms |
1 |
|
nf-kappa b - metabolism |
1 |
|
nf-κb |
1 |
|
noninvasive analysis |
1 |
|
nootropic agents - therapeutic use |
1 |
|
ntf-1 |
1 |
|
nuclear proteins - genetics - physiology |
1 |
|
nuclear proteins - physiology |
1 |
|
oblongifolin m |
1 |
|
oligomerization |
1 |
|
omv |
1 |
|
omvs |
1 |
|
oocytes - physiology |
1 |
|
osmolar concentration |
1 |
|
outer membrane protein |
1 |
|
outer membrane vesicles |
1 |
|
outer-membrane vesicles |
1 |
|
oxidoreductases |
1 |
|
p301s tau mice |
1 |
|
pancreatic neuroendocrine tumor |
1 |
|
pathogenesis |
1 |
|
pc12 cells |
1 |
|
pei doping |
1 |
|
phagocytosis |
1 |
|
phenotype |
1 |
|
phosphatidylinositol 3-kinases - metabolism |
1 |
|
phosphoproteins |
1 |
|
phosphoproteins - physiology |
1 |
|
phytotherapy |
1 |
|
plant preparations - adverse effects - therapeutic use |
1 |
|
plants, medicinal |
1 |
|
plasmids |
1 |
|
platelet secretion |
1 |
|
polyethylenimine |
1 |
|
portable two-way regulation |
1 |
|
precipitin tests |
1 |
|
protamine |
1 |
|
protein isoforms - genetics - metabolism |
1 |
|
protein-tyrosine kinases - metabolism |
1 |
|
proteins - genetics |
1 |
|
purification |
1 |
|
purkinje cells - metabolism - ultrastructure |
1 |
|
pyruvate dehydrogenase complex deficiency disease |
1 |
|
quantitative engineering biology |
1 |
|
quantitative proteomics |
1 |
|
randomized controlled trials as topic |
1 |
|
rats |
1 |
|
receptor protein-tyrosine kinases |
1 |
|
receptor‐binding domain |
1 |
|
recombinant fusion proteins - genetics - metabolism |
1 |
|
regulatory sequences, nucleic acid - genetics |
1 |
|
repressor proteins - genetics |
1 |
|
repressor proteins - genetics - physiology |
1 |
|
restriction mapping |
1 |
|
riboswitch |
1 |
|
rna, messenger |
1 |
|
saccharomyces cerevisiae |
1 |
|
saccharomyces cerevisiae - genetics |
1 |
|
saccharomyces cerevisiae proteins |
1 |
|
salmonella typhi |
1 |
|
sars-cov-2 detections |
1 |
|
sars‐cov‐2 |
1 |
|
signal integration |
1 |
|
signal transduction |
1 |
|
signal transduction - drug effects |
1 |
|
signaling pathway |
1 |
|
soluble amyloid precursor protein-β |
1 |
|
species interaction |
1 |
|
spycatcher-spytag |
1 |
|
staphylococcus aureus vaccine |
1 |
|
stress, mechanical |
1 |
|
suppression, genetic |
1 |
|
synthetic circuit |
1 |
|
synthetic genetic circle |
1 |
|
synthetic life |
1 |
|
synthetic microbial community |
1 |
|
systematic review |
1 |
|
t- cell responses |
1 |
|
tailless |
1 |
|
targeted ifnγ therapy |
1 |
|
tau |
1 |
|
tau pathology |
1 |
|
tcdd exposure |
1 |
|
terpenoid |
1 |
|
tg crnd8 mice |
1 |
|
therapeutics |
1 |
|
thermogenesis |
1 |
|
tnf-α |
1 |
|
torso tyrosine kinase receptor |
1 |
|
traditional chinese medicine |
1 |
|
trans-activators |
1 |
|
transcription |
1 |
|
transcription factors - genetics |
1 |
|
transcription factors - genetics - metabolism |
1 |
|
transcription factors - metabolism |
1 |
|
transcription factors - physiology |
1 |
|
transcription, genetic |
1 |
|
transcriptional silencer |
1 |
|
transforming growth factor beta - genetics |
1 |
|
transgenic crnd8 |
1 |
|
treatment outcome |
1 |
|
tregs |
1 |
|
trithorax-like |
1 |
|
tryptophan metabolism |
1 |
|
tumor immunity |
1 |
|
tumor immunosuppression |
1 |
|
tumor necrosis factor-alpha - pharmacology |
1 |
|
tumor-targeting |
1 |
|
twist |
1 |
|
type iii secretion system |
1 |
|
typhoid |
1 |
|
u937 cells - drug effects |
1 |
|
unnatural nucleic acids |
1 |
|
urine |
1 |
|
vascular cell adhesion molecule-1 - biosynthesis |
1 |
|
verapamil |
1 |
|
vesicle transport |
1 |
|
viable region |
1 |
|
von willebrand factor |
1 |
|
vγ9vδ2 t cells |
1 |
|
zygote - physiology |
1 |
|
γδ t cells |
1 |
|
‘click’ display |
1 |
|
上皮细胞-间充质转化 |
1 |
|
间充质干细胞 |
1 |
